But if were really talking about treating obesity, those microdosing doses are not going to be effective for most people, and so I worry people are going to pay for it cause its cheaper and then its not going to work for them and theyre going to think heres one more thing thats not working for me. In Diet, Drugs, and Dopamine, former FDA Commissioner David A
Dramatic weight loss seen in clinical trials prompted this new indication
They produce real results but typically not as dramatic as injections
The inflammation-marker data
The expected FDA decision on oral semaglutide for obesity (anticipated Q4 2025) is a potential catalyst for further portfolio expansion, market leadership reinforcement, and revenue growth
GLP-1 phishing scams increase Florida still has not imported a single pill, patients seeking GLP-1 medicines at increased risk from phishing scams, the counterfeit medicine news from three other countries